Joseph Kauer

18PUBLICATIONS
121CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 18, 2026
Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.

|Oct 13, 2025
Acquired and Selected: Tracking Antigen Escape during T Cell-Redirecting Therapies in Multiple Myeloma.

Joseph Kauer, Niels Weinhold, Marc S Raab

|Apr 23, 2025
Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma.

Jan H Frenking, Xiang Zhou, Kai Rejeski

|Dec 11, 2024
Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study.

Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff

|Sep 18, 2024
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML.

Julia M Unglaub, Richard F Schlenk, Jan Moritz Middeke

|Apr 29, 2024
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.

Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta

Pageof 3

Frequent Collaborators

5 joint publications

Helmut R Salih

4 joint publications

Melanie Märklin

3 joint publications

Bastian von Tresckow

3 joint publications

Latifa Zekri